ESC 365 - Imaging for prevalence assessment of cardiac transthyretin amyloidosis in patients > 60 years hospitalized in cardiology : the IMPACT study

Back

ESC Professional Premium Access

Imaging for prevalence assessment of cardiac transthyretin amyloidosis in patients > 60 years hospitalized in cardiology : the IMPACT study

Session: Cardiac amyloidosis: prevalence, genetics, and natural history

Topic: Imaging

Speaker: Doctor E. Beard (Poitiers, FR)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Elsa Beard

University Hospital of Poitiers, Poitiers (France)

0 follower

8 more presentations in this session

Characterization and natural history of phenotypes in hereditary transthyretin amyloidosis

Speaker: Doctor G. Saturi (Bologna, IT)

Predictive Value of high-sensitivity cardiac troponin T in patients undergoing 99mTc pyrophosphate scintigraphy for suspected transthyretin amyloid cardiomyopathy

Speaker: Doctor L. De Michieli (Padova, IT)

Prevalence of cardiac amyloidosis in patients undergoing carpal tunnel release with amyloid deposition in removed tenosynovium

Speaker: Doctor S. Takashio (Kumamoto, JP)

Transtyretin cardiac amyloidosis in the elderly patient: always a wild type?

Speaker: Doctor J. Costantino (Rome, IT)

The clinical significance of transthyretin gene variant homozygosity in variant ATTR-CM

Speaker: Doctor Y. Razvi (London, GB)

Access the full session

Cardiac amyloidosis: prevalence, genetics, and natural history

Speakers: Doctor E. Beard, Doctor G. Saturi, Doctor L. De Michieli, Doctor S. Takashio, Doctor J. Costantino...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources